Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link

Volume 32, Number 3—March 2026

Dispatch

Extraintestinal Entamoeba moshkovskii Infection, Eastern India

Sanjib Kumar Sardar, Ajanta Ghosal1, Tapas Haldar1, Basudev Ganguly, Koushik Das, and Sandipan GangulyComments to Author 
Author affiliation: The University of Tokyo, Bunkyo, Japan (S.K. Sardar); ICMR–National Institute for Research in Bacterial Infections, Kolkata, India (S.K. Sardar, A. Ghosal, T. Haldar, B. Ganguly, S. Ganguly); Assam University, Guwahati, India (K. Das).

Main Article

Figure 2

PCR amplification of DNA from an extraintestinal Entamoeba moshkovskii infection in a patient from eastern India. A) PCR amplification of the 18S rRNA locus of E. moshkovskii using DNA extracted from a splenic aspirate. The expected product size is 779 bp. B) PCR amplification of the chitinase locus of E. moshkovskii using DNA extracted from spleen aspirate samples. The expected product size is 480 bp. C) Amplification of the 18S rRNA locus of E. moshkovskii by PCR using DNA extracted from a stool sample. The expected product size is 779 bp. Lane 1, PCR product from patient sample; lane 2, positive control (E. moshkovskii genomic DNA); lane 3, E. histolytica genomic DNA; lane 4, negative control.

Figure 2. PCR amplification of DNA from an extraintestinal Entamoeba moshkovskii infection in a patient from eastern India. A) PCR amplification of the 18S rRNA locus of E. moshkovskii using DNA extracted from a splenic aspirate. The expected product size is 779 bp. B) PCR amplification of the chitinase locus of E. moshkovskii using DNA extracted from spleen aspirate samples. The expected product size is 480 bp. C) Amplification of the 18S rRNA locus of E. moshkovskii by PCR using DNA extracted from a stool sample. The expected product size is 779 bp. Lane 1, PCR product from patient sample; lane 2, positive control (E. moshkovskii genomic DNA); lane 3, E. histolytica genomic DNA; lane 4, negative control.

Main Article

1These authors contributed equally to this article.

Page created: February 20, 2026
Page updated: March 20, 2026
Page reviewed: March 20, 2026
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external